Advertisement
YOU ARE HERE: LAT HomeCollectionsRitonavir Drug
IN THE NEWS

Ritonavir Drug

FEATURED ARTICLES
NEWS
March 1, 1996 | MARLENE CIMONS, TIMES STAFF WRITER
A federal advisory committee Thursday recommended government approval of a powerful new drug that recent research has shown can decrease or prevent AIDS-related complications and prolong life in very sick patients. The drug, ritonavir, developed by Abbott Laboratories, is one of a new class of potent antiviral drugs called protease inhibitors that has excited AIDS specialists.
ARTICLES BY DATE
CALIFORNIA | LOCAL
January 3, 1997 | LORI HAYCOX
Lorna Horn gets out of bed at 6:30 a.m. to shower and dress for school. Then she walks Dolly, the family's rambunctious Jack Russell terrier. These may not be big achievements for most 13-year-olds, but to Lorna and her parents, they are miraculous. A year ago, Lorna, who has AIDS, couldn't face mornings. Her stomach ached from the massive doses of drugs she took to stay alive. She didn't have the energy to shower, go to school or care for her dog. Often, she went to the hospital.
Advertisement
NEWS
March 2, 1996 | MARLENE CIMONS, TIMES STAFF WRITER
Moving with unusual speed, the Food and Drug Administration on Friday announced full approval of a powerful new AIDS drug that has been shown to reduce episodes of illness and prolong the lives of very sick patients. The licensing of ritonavir comes a scant 24 hours after an FDA advisory committee recommended that the drug be approved for use only in advanced cases of the disease.
NEWS
March 2, 1996 | MARLENE CIMONS, TIMES STAFF WRITER
Moving with unusual speed, the Food and Drug Administration on Friday announced full approval of a powerful new AIDS drug that has been shown to reduce episodes of illness and prolong the lives of very sick patients. The licensing of ritonavir comes a scant 24 hours after an FDA advisory committee recommended that the drug be approved for use only in advanced cases of the disease.
CALIFORNIA | LOCAL
January 3, 1997 | LORI HAYCOX
Lorna Horn gets out of bed at 6:30 a.m. to shower and dress for school. Then she walks Dolly, the family's rambunctious Jack Russell terrier. These may not be big achievements for most 13-year-olds, but to Lorna and her parents, they are miraculous. A year ago, Lorna, who has AIDS, couldn't face mornings. Her stomach ached from the massive doses of drugs she took to stay alive. She didn't have the energy to shower, go to school or care for her dog. Often, she went to the hospital.
BUSINESS
July 5, 2007 | From Bloomberg News
Abbott Laboratories, the third-largest U.S. drug maker, agreed to cut the price of its new AIDS treatment drug by 30% in Brazil, two months after the country broke the patent on a similar drug made by Merck & Co. Abbott will reduce the price of its new version of the Lopinavir/ritonavir drug, known as Kaletra, to 73 cents from $1.04 this year and to 68 cents in 2008, Brazilian Health Minister Jose Gomes Temporao said Wednesday at a ceremony in Brasilia.
NEWS
February 1, 1996 | MARLENE CIMONS, TIMES STAFF WRITER
Scientists today will present the first compelling proof that a new family of potent AIDS drugs can decrease or even prevent AIDS-related complications--and prolong life. Researchers studying ritonavir, an experimental drug developed by Abbott Laboratories, will tell a major AIDS conference here that patients already very sick with AIDS who took the drug suffered far fewer symptoms of AIDS and lived significantly longer than those taking a placebo.
NEWS
March 1, 1996 | MARLENE CIMONS, TIMES STAFF WRITER
A federal advisory committee Thursday recommended government approval of a powerful new drug that recent research has shown can decrease or prevent AIDS-related complications and prolong life in very sick patients. The drug, ritonavir, developed by Abbott Laboratories, is one of a new class of potent antiviral drugs called protease inhibitors that has excited AIDS specialists.
Los Angeles Times Articles
|